A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

In collaboration with a foundation that breeds service dogs for the visually impaired, researchers at the School of ...

Watkins sustained a torn ACL during USC's second-round win over Mississippi State. The injury occurred in the first quarter ...

Additionally, bone density diminishes significantly—astronauts can lose up to 20% of bone mass in areas such as the spine and pelvis. This happens because the body adapts to the absence of ...

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

Adeno-associated virus (AAV)–mediated gene therapy was one of the focal points of this year's Muscular Dystrophy Association conference. Here, Barry Byrne, MD, PhD, University of Florida, speaks to ...

Viewing AI assistants as full-fledged partners rather than as tools with both benefits and limitations risks unexpected ...

Bone Density Loss: Prolonged exposure to microgravity can also lead to decreased bone density, increasing the risk of fractures. Research indicates that astronauts can lose around 1% of their bone ...

How Does EMS Work? Ever ponder the magic behind EMS, transforming electric pulses into robust muscles? This technology employs gentle currents to induce muscle contractions, akin to a workout stimulus ...

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due to market skepticism. Risks include the ex-US trial locations for GBS and ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.